Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

However, a critical barrier to the progress of the field is the lack of knowledge about these microscopic cancer lesions. We will specifically focus on micrometastases in bone, an organ most ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

BoXer releases this 'payload' locally at the site of bone lesions, offering a dual therapeutic benefit—bone regeneration and localized myeloma control," adds Dr. Anja Seckinger of TORC.

New innovative local treatment for osteolytic bone disease in multiple myeloma Date: January 14, 2025 Source: Vrije Universiteit Brussel Summary: A team of researchers has developed a new ...

leading to debilitating bone lesions in 80% of patients. These lesions cause severe pain and fractures that often fail to heal, and within, a vicious cycle takes place that supports tumor survival ...

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ ...

Bone pain. Joint pain ... about the epigenetic landscape of the tumors that showed evidence of metastasis from the tumors that did not metastasize. So, Yustein began examining the samples at ...